chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Acute hypoxemic respiratory failure, resolved - Secondary to COVID-19 infection, bronchitis - CTPA: no evidence of PE or lobar consolidation, bilateral bronchial thickening suggestive of bronchitis - Strongly encourage pulmonary hygiene with I-S, vibratory pep therapy, encourage cough and deep breathing - Now on RA   COVID-19 - Presented with: fatigue, cough and hypoxia - Symptom onset: 4/6/23 - Positive COVID-19: 4/7 at FVD rapid test, PCR positive 4/9 at RMH - Vaccination status: vaccinated with Moderna with last dose 5/4/22 - CT Chest without evidence of PE or lobar consolidation - Received 2 doses of IV Remdesivir - Complete 5 day course of Decadron, can extend at SNF if indicated - Was prescribed Molnupiravir outpatient but has not yet started this medication (not available inpatient)   Bronchitis - Suspect viral bronchitis; however, given increased sputum production and CTPA evidence of bronchitis, cannot completely exclude bacterial component - Pulmonary hygiene as per above. - Procalcitonin WNL - Benefit of 5 days of treatment with azithromycin outweighs potential risk at this point - Azithromycin x 5 days, continue Robitussin around-the-clock   Elevated troponin - Troponin mildly elevated on admission without clinical signs or symptoms consistent with ACS - Per history has had mildly elevated troponin levels of 15-18 in the past - ECG notable for first-degree AV block without acute ST or T wave changes - Continue to monitor clinically, no further work-up indicated at present   Mild intermittent asthma - Not in acute intubation at present - Continue Albuterol MDI as needed   Esophagitis/duodenal ulcer - EGD 1/2023 with esophagitis and duodenal ulcer, GI recommended 8 weeks of PPI twice daily, de-escalated to once daily 3/28 - Continue Protonix once daily Cognitive impairment Vascular dementia - Chronic, suspect secondary to small vessel cerebrovascular disease - Continue Donepezil 5mg once daily   Essential tremor - Continue home nightly Gabapentin, Primidone and daily Propranolol   Mood disorder - Continue home Wellbutrin   Insomnia - Continue nightly Remeron and Melatonin   Cerebrovascular disease - CT imaging of the head (2022 (with chronic left frontal and bilateral cerebellar infarcts as well as chronic microvascular changes - Continue home ASA and statin   Right lower extremity weakness - Chronic, longstanding issue; was getting PT/OT without significant improvement in functional status over the last several hospitalizations - PT/OT consulted, recommending up to 5 (currently at ALF), discharge to SNF   Chronic lymphocytic lymphoma - Follows with Dr., currently undergoing outpatient surveillance - No active treatment plan at this time   Abnormal CT chest - Left breast 9 mm soft tissue nodule noted on CTPA - Given goals of care/DNRCC status would not recommend any further investigation at this time, can follow-up with PCP for further work-up outpatient if warranted; discussed with daughter, whom is in agreement
HCP reporting a temperature excursion. HCP confirmed this vaccine was administered on 12MAY2023 after the temperature excursion. Additional AE's filed in 02390911, 02390925, 02390931, 02390933. No other AEs, No PQCs.   ?    Names of vaccines invol; HCP reporting a temperature excursion. HCP confirmed this vaccine was administered on 12MAY2023 after the temperature excursion. Additional AE's filed in 02390911, 02390925, 02390931, 02390933. No other AEs, No PQCs.   ?    Names of vaccines invol; Information has been received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 12-MAY-2023, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot number 1938967 and expiration date on 25-APR-2024 (administration route was not provided) for prophylaxis. No adverse effects were reported.  The vaccine had thee temperature excursions, one of 1.8 Celsius degrees (C) for 0 hours 9 minutes; the second of 1.3 C for 1 hour 12 minutes and the last excursion of 1.2 C for 1 hour 58 minutes. It was confirmed that no previous temperature excursions occurred.
body ache and chills; body ache and chills; This is a spontaneous report from a contactable consumer.   A female patient of an unspecified age received bnt162b2 (BNT162B2, Batch/lot # EK9231) at single dose on 06Jan2021 for Covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced body ache and chills on an unspecified date in Jan2021. No treatment received. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Patient was very apprehensive and nervous before getting any immunizations. She was very fearful. After getting injections she felt weak and was dizzy. We had her lay down until she felt better. When she went to leave facility 10 minutes she fainted. Laid her on floor-elevated her feet. Took vitals. Epi - on standby but not used. Patient recovered well and left with her mother 15 min later. Follow up with mother next day - everything OK.
Info has been received from a physician concerning an 8 year old white male with asthma and allergies who on 4/26/99 was vaccinated SC with a 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination. The "week of 3/14/05", the pt developed a case of breakthrough varicella with itching, no fever and 40 pox covering his body. It was reported that the pt's rash was consistent with mild varicella. Unspecified medical attention was sought. No m3edication was given. There was no product quality complaint involved. Subsequently, the pt recovered. Additional info is not expected.
Started having flu symptoms 3 hours after shot.  By following morning had a temp of 105 and was not responsive.  Rushed to Hospital by ambulance.  Not responsive for 2 days.  In hospital for 4 days.  Hospital concluded she had a temp induced seizure.  Worst response they had seen.  Still rests and sleeps more than normal.
Rash beginning one week after receiving MMR, Varicella + HepA vaccine.  Rash on back and 5 total lesions- a few appearing like typical chickenpox lesions- tiny fluid filled vesicle with re patch @ base.  Rash present x3d @ clinic visit.
Maculopapular pruritic rash beginning 8 hours later on both arms and legsl Not responsive to antihistamines, but responding to short course prenisone (today is day 5 of that)
About 2 hours after injection pt got chills and nausea...could not get warm & felt very nauseated.  Lasted for about 12 hours.
Healthcare provider had not stored the vaccine properly; She never got to her second Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Healthcare provider had not stored the vaccine properly) and PRODUCT DOSE OMISSION ISSUE (She never got to her second Moderna shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced PRODUCT STORAGE ERROR (Healthcare provider had not stored the vaccine properly) and PRODUCT DOSE OMISSION ISSUE (She never got to her second Moderna shot). In July 2021, PRODUCT STORAGE ERROR (Healthcare provider had not stored the vaccine properly) and PRODUCT DOSE OMISSION ISSUE (She never got to her second Moderna shot) had resolved.            No concomitant medications were provided.  No treatment medications were reported.  The patient had received the first shot of Moderna vaccine in July 2021. Following that, she received the shingles shot and she never got to her second Moderna shot. The caller mentioned that she was not going to receive the second dose.
extreme hoarseness;loss of taste;loss of smell;pain armpit lt arm;nasal & chest congestion;
2/24/05 note: Information taken from the scientific literature article. Subject is a 24 year old female with  no prior history of skin problems, rhinitis or asthma and no family history of allergic diseases. The dose, date, and lot # of the Anthrax vaccine are unk. Concomitant medications at the time of the event, other vaccine history, concomitant illness at the time of the vaccination, and previous reactions to vaccines are unk. In 1998, after the initial series of three Anthrax vaccinations, the pt complained of eczema. The rash appeared as an eczematous dermatitis of her arms, thighs and trunk. Two days after the 4th vaccine, new macules and papules developed on her trunk and extremities. Eruption on her trunk and extremities worsened after the 5th vaccination. After the first three Anthrax vaccinations, topical steroids were used to treat the rash which improved over a few months. After the 5th Anthrax vaccination, oral steroids improved the rash after several days. A skin biopsy performed revealed spongiotic dermatitis with eosinophils. A skin prick test to Anthrax vaccine and tests of complement and immune complexes were negative. No hematologic, hepatic or renal abnormalities, nor evidence of inflammation or autoantibodies were detected per laboratory evaluation. At the time of this report, it is unk if the pt recovered from these events.
This case was reported by a physician and described the occurrence of generalized rash in a 31-year-old female subject who was vaccinated with Fluarix (GlaxoSmithKline).  On 28 November 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown, right arm).  On 02 December 2007, 4 days after vaccination with Fluarix, the subject experienced generalized rash on multiple body parts.  The subject was treated with steroid injection and topical, as well as Claritin.  At the time of reporting the event was improved.  Follow-up information was received on 11 February 2008 via a physician, who reported that no biopsy was performed on the rash.  At the time of reporting, the event was resolved.  The reporting physician considered the event to be related to vaccination with Fluarix.
This spontaneous prospective pregnancy report as received from a nurse refers to a 21 year old female patient with no drug allergies. The patient's medical history included spontaneous abortion in June 2013, caesarean section and headaches. The patient is gravida 2 and has one child living. The patient became pregnant on 29-JUL-2014 with last menstrual period (LMP): 15-JUL-2014. Estimated Date of Delivery (EDD) is 21-APR-2015. Nurse stated that on 26-AUG-2014 ("yesterday") the patient was vaccinated with her third dose of GARDASIL (0.5 ml intramuscularly in the right arm, lot # K006449, expiration date: 19-JUN-2016). Concomitant therapies included IMITREX. Initial exposure to GARDASIL was at 6 weeks. A urine pregnancy test was taken and was positive. However, nurse stated that patient did not wait for the results, she wanted the GARDASIL vaccination. Nurse also stated that post vaccination, patient told her she knew she was pregnant, due to a home urine pregnancy test, but wanted to get the third dose of GARDASIL completed. Patient was not experiencing any adverse effects. The pregnancy outcome was outcome pending. Additional information is not expected, because there was no consent to contact physician.
PATIENT STATED HE FELT SEVERE PAIN AND COULDN'T SLEEP THAT SAME NIGHT OF THE VACCINE.  HIS BICEPS/TRICEPS WERE SWOLLEN.  HIS ARM WAS SWOLLEN DOWN TO THE ELBOW.  PATIENT STATED TAKING IBUPROFEN DID HELP A LITTLE BIT OF THE SWELLING BUT NOT MUCH.  PATIENT WILL CALL MD TO FOLLOW-UP.
Racing heart rate (99 bpm resting), heart palpitations (fluttering, interruptions), pounding heart, increased blood pressure for 6 days after vaccine. On day 7, heart palpitations ceased and blood pressure lower, heart still racing and heart still pounding.
Severe headache behind left eye and temple, debilitating joint pain and body aches requiring bedrest for 24 hours, malaise. Hydrocodone and tylenol and bedrest.
Sat. 03/26- couple of bumps on her, Sun and Mon 03/27-03/28-more came on her forehead, hair line, and ear. Small red bump pus came out.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hyperthyroidism" (unspecified if ongoing); "elevated rheumatoid factor" (unspecified if ongoing); "Known allergies: Gluten" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Known allergies: amoxicillin, reaction(s): "Known allergies: Amoxicillin".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Extreme soreness within 1.5 hours after the shot was administered.  I noticed that the administrator gave the vaccine much higher on my left shoulder than I expected or have had before.  The pain began to subside about a week after the initial vaccine, but came back within a couple days.  Extreme pain in the front part of my shoulder, especially when dressing/undressing, turning the wheel of my car, at work (bar tending), putting my seatbelt on.  Anything where the arm crossed my torso made it worse.  I visited my physician and he determined an impingement in my rotator cuff, which could be from the needle hitting the bursa (from being too high).  I have been icing regularly, and applying Voltaren gel 4 times/day for a week (so far).  If the pain continues for a couple more weeks, a cortisone shot is the next course of action.
When I interviewed pt upon intake, she told me that she had felt faint after previous vaccinations.  She denied any other type of reaction.   My tech and I observed her closely, and she began to complain of dizziness and feeling hot about 5 minutes after receiving vaccine.  I sat with her, gave her water and candy.  She then told me her dizziness was getting worse and asked to lie down.  I took her pulse which was WNL..  She also had some Gatorade.  We called paramedics as a precaution.  They assessed her and she continued to improve.  She was able to sit in a chair and felt fine after 5 more minutes.  She left pharmacy.
Patient fainted and hit his head. Paramedics were called to help him. Pt had deep cut on eyebrow and slight cut and fracture on side of his nose. Pt received stitches on his eyebrow. Pt also has black eye. (all on left side).
Vomited within 2 mins of vaccine. Followed by chest tightness/ B eye lid swelling. (no wheeze and no vital signs) - Benadryl/ Orpred administered.
Bodyache; Painful to walk; Muscle spasm; Sick feeling; Soreness of body; Chills; High Fever; Fatigued; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Bodyache), GAIT DISTURBANCE (Painful to walk), MUSCLE SPASMS (Muscle spasm), MALAISE (Sick feeling) and PAIN (Soreness of body) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by reporter.  Concomitant products included ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) and FISH OIL for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (Bodyache), GAIT DISTURBANCE (Painful to walk), MUSCLE SPASMS (Muscle spasm), MALAISE (Sick feeling), PAIN (Soreness of body), CHILLS (Chills), PYREXIA (High Fever) and FATIGUE (Fatigued). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN (Bodyache), GAIT DISTURBANCE (Painful to walk), MUSCLE SPASMS (Muscle spasm), MALAISE (Sick feeling), CHILLS (Chills), PYREXIA (High Fever) and FATIGUE (Fatigued) had resolved and PAIN (Soreness of body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received on 17-OCT-2019 from a consumer refers to a 71 year old female patient with sulfa allergy, penicillin allergy, x-ray dye allergy and drug allergies to LEVAQUIN, ZITHROMAX, DEMEROL, FLOXIN, and FERROCITE. The patient's medical history included herpes zoster. In the second week of June 2016, the patient was vaccinated with ZOSTAVAX, about seven months after having shingles. The patient requested the ZOSTAVAX so that she wouldn't get shingles again. Concomitant therapies included unspecified vitamins and supplements. About two to three weeks after the shot, the patient broke out all over her body. It started with one spot on her neck and her leg. The unspecified rash then spread all over her body - on her arms, under her breasts, on her stomach and down her legs. The patient says she looked like a zebra and had to wear long skirts to hide her legs. At an unspecified time in July, the patient visited an unspecified urgent care facility. The urgent care facility diagnosed her with an unspecified parasitic infection. The patient then went to her unspecified primary care provider. The primary care provider referred her to an unspecified dermatology office. In this dermatology office, the patient saw an unspecified physician assistant. The physician assistant diagnosed her with rash and bacterial folliculitis. The physician assistant referred the patient to an unspecified allergist who referred her back to the dermatologist. The patient then returned to the dermatology office a second time and saw an unspecified dermatologist who diagnosed her with shingles. The patient reported that the shingles were worse the second time after having ZOSTAVAX than they were the first time she experienced them. As of the date of this report, the patient reported that it still looks like she has "chicken pox on her stomach and arms" and is still applying unspecified steroid cream. No further information provided. Additional information has been requested.
pt came back feeling lethargic and weak stated she did not have anything to eat so pt was given apple juice pt confusion became elevated and pt unable to keep eyes open pt didint know where she was ems called pt had panic attack when 5 ems personnel were in the room calmed down then sent to the hospital pts daughter came and went to hospital with her
pt recvd vax; exp generalized erythema on trunk, face & extremities 7 days after a local rxn on inject site; 4jun93 wbc 10,4000 diff: segs 17, Bands 6, Lymphs 70, Eos 4;
Information has been received from a registered nurse (RN) concerning a female with an allergy to erythromycin who was vaccinated with a second dose of Recombivax HB at a hospital in January of 2007. Concomitant therapy included folic acid, prednisone and FIORICET TABLETS. Subsequently, the patient experienced thrombocytopenia. It was reported that the patient has received two doses of Recombivax HB so far but it was unknown if the thrombocytopenia occurred with dose 1 or dose 2 or with both. Unspecified medical attention was sought, "bloodwork showed that patient's levels went down to 20,000". The patient was treated with steroids and her thrombocytopenia had only slightly improved. It was reported that the patient will not be given dose 3. As of 23-Mar-2007, the patient's status was unknown. No product quality complaint was involved. Follow-up information was received on 07-JUN-2007 indicating that the patient was hospitalized as a result of thrombocytopenia. A platelet transfusion was performed and the patient was treated with IVIG. At the time of this report the patient was "still being treated". It was indicated that the patient's thrombocytopenia occurred in March 2007 after receiving his second dose of Recombivax HB in January 2007. Additional information has been requested.
Developed painful nodule rash on legs 3 days (10/5/12) after flu vaccination (10/2/12). Had fevers, malaise and flu like symptoms. Seen in ER on 10/5/12 Dx erythema nodosum.
This spontaneous report as received from a medical assistant referring to a 4 year old female patient. Concurrent conditions and medical history of the patient were not provided. On 14-SEP-2015, the patient was vaccinated in right thigh with dose of improperly stored (Oka/Merck) VARIVAX (dose and route were unspecified) (lot # L018001, expiration date: 19-MAY 2017). Concomitant therapies included M-M-R II vaccinated in left thigh. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
Moderna COVID-19 Vaccine EUA Dizziness and headache within 1 hour after 4-10 headache off & on 4-11 headache off & on, sore arm 4-12 stiff neck, headache, exhaustion, chills, sore arm 4-13 muscle aches, headache 4-14 tiredness, headache, chills, shortness of breath (2x) 4-15 muscle aches, dizziness, shortness of breath (1x) itchy skin 4-16 aches, headache, noticed raised red welts in sporatic area's - legs/stomach, nausea
Pt recvd 1st & 2nd dose of Hep B AUG90 & 3SEP90 & approx 10 days following 2nd vax pt devel a rash; rash eventually resolved; lab eval in DEC90 & DEC91 revealed anti-HBs level of 32 & 0;
Chest pain & tightness with palpitations within 48 hours. Attempted to ignore, then palpitations became so bad, I my PCM in late Feb/early March & was given a 2 wk Halter monitor which showed PSVT up to 180 beats per minute. Subsequently sent to Cardiologist and started on B blocker for PVST/PVCs. Admitted to Hospital May 2022 for PSVT, Palpitations, generalized chest tightness & feeling ill, started Cardizen XR. From there referred to Cardiologist who recommended ablation. Currently, being seen by Cardiologist. Another halter done, PSVT when not on Cardizem XR. Must resume cardiac meds lifelong. No heart issues prior to 3rd COVID booster. I have not felt the same since. Now I have a permanent deployment limitation code due to this diagnosis.
02/18/04: Administered at clinic.  02/20/04: Presented to clinic complaining of tenderness, redness and a lump to left deltoid.  States symptoms began yesterday and has gotten worse today.  Since 02/19/04 when arm started getting red.  No complaints of temp. child moving arm in full motion, eating/drinking and playing as usual.  Will follow up with mother at 2:45pm today 02/20/04.
Information has been received from a health professional concerning a 19 week old male who on 02-OCT-2007 was vaccinated with a dose of Rotateq. on 08-OCT-2007 the patient presented to the office with diarrhea which were guaiac positive. It was reported that there was no frank red blood. All other stool studies were negative. Upon internal review, the patient's hematochezia was considered to be an other important medical event. This is one of several reports received from the same source. Additional information has been requested.
Vomiting 3 days (still going) loss of feeling in legs for about half an hour (completely no feeling and unable to stand or walk then uncontrollable shaking in legs since 3/29 at 5 pm. Still shaking although less. I can walk by using furniture to balance. (3/30 at 4 pm). Profuse sweating for last 24 hours.